03rd week of 2017 patent applcation highlights part 20 |
Patent application number | Title | Published |
20170015674 | PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR | 2017-01-19 |
20170015675 | SUBSTITUTED TRICYCLICS AND METHOD OF USE | 2017-01-19 |
20170015676 | PHOSPHONIC ACID CATALYST IN DEHYDRATIVE CYCLIZATION OF 5 AND 6 CARBON POLYOLS WITH IMPROVED COLOR AND PRODUCT ACCOUNTABILITY | 2017-01-19 |
20170015677 | NEW TRICYCLIC QUINONE DERIVATIVE | 2017-01-19 |
20170015678 | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | 2017-01-19 |
20170015679 | Novel Heterocyclic Derivatives as Modulators of Kinase Activity | 2017-01-19 |
20170015680 | N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | 2017-01-19 |
20170015681 | IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-19 |
20170015682 | POLYMORPHIC MIXTURE OF RIFAXIMIN AND ITS USE FOR THE PREPARATION OF SOLID FORMULATIONS | 2017-01-19 |
20170015683 | PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2017-01-19 |
20170015684 | METHOD FOR PRODUCING 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO, AND PRECURSOR OF 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO | 2017-01-19 |
20170015685 | ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY | 2017-01-19 |
20170015686 | Substituted Bis Indenyl Metallocene Catalyst Compounds Comprising -Si-Si- Bridge | 2017-01-19 |
20170015687 | ORGANIC TITANIUM DERIVATIVE AND PROCESS FOR THE PREPARATION THEREOF, INK CONTAINING THE DERIVATIVE AND CERAMIC DIGITAL PRINTING METHOD THAT USES THE INK | 2017-01-19 |
20170015688 | SUBSTITUTED BISPHENYL BUTANOIC PHOSPHONIC ACID DERIVATIVES AS NEP INHIBITORS | 2017-01-19 |
20170015689 | PYRIMIDINE DERIVATIVES | 2017-01-19 |
20170015690 | TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY | 2017-01-19 |
20170015691 | Novel Benzoxaphosphole Compounds and a Process for Preparation Thereof | 2017-01-19 |
20170015692 | PROCESS FOR TREATING BLACK LIQUOR | 2017-01-19 |
20170015693 | ACRYLAMIDE-BASED CONDUCTIVE COMPOUNDS, AND METHODS OF PREPARATION AND USES THEREOF | 2017-01-19 |
20170015694 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | 2017-01-19 |
20170015695 | PREPARATION OF MONOSACCHARIDES, DISACCHARIDES, TRISACCHARIDES, AND PENTASACCHARIDES OF HEPARINOIDS | 2017-01-19 |
20170015696 | SOLID STATE FORMS OF SOFOSBUVIR | 2017-01-19 |
20170015697 | SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE | 2017-01-19 |
20170015698 | NUCLEIC ACID POLYHEDRA FROM SELF-ASSEMBLED VERTEX-CONTAINING FIXED-ANGLE NUCLEIC ACID STRUCTURES | 2017-01-19 |
20170015699 | Partially Neutral Single-Stranded Oligonucleotide | 2017-01-19 |
20170015700 | COMPOUNDS WITH A COMBINED ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS TOGETHER WITH AN ANTI-INFLAMMATORY ACTION, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF SKIN AND HAIR | 2017-01-19 |
20170015701 | LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME | 2017-01-19 |
20170015702 | OPTIMIZED METHOD FOR ANTIBODY CAPTURING BY MIXED MODE CHROMATOGRAPHY | 2017-01-19 |
20170015703 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | 2017-01-19 |
20170015704 | AMINOTHIAZOLES AND THEIR USES | 2017-01-19 |
20170015705 | PYRROLE COMPOUNDS AS GRANZYME B INHIBITORS | 2017-01-19 |
20170015706 | PROLINE COMPOUNDS AS GRANZYME B INHIBITORS | 2017-01-19 |
20170015707 | COVALENT GRANZYME B INHIBITORS | 2017-01-19 |
20170015708 | CHEMOKINE BINDING POLYPEPTIDES FOR TREATING AUTOIMMUNITY, AND INFLAMMATION | 2017-01-19 |
20170015709 | GLYCOPEPTIDE DERIVATIVES FOR THE PRESERVATION AND PROTECTION OF BIOLOGICAL MATERIALS AND MICROORGANISMS | 2017-01-19 |
20170015710 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | 2017-01-19 |
20170015711 | MATERIALS AND METHODS FOR PRODUCING CLEAVED, HIV-1 ENVELOP GLYCOPROTEIN TRIMERS | 2017-01-19 |
20170015712 | COMPOSITIONS AND METHODS FOR TREATING, INCLUDING PREVENTING, PARVOVIRUS INFECTIONS AND RELATED DISEASES | 2017-01-19 |
20170015713 | Fusion Protein Comprising Diphtheria Toxin Non-Toxic Mutant CRM197 or Fragment Thereof | 2017-01-19 |
20170015714 | Synthetic Polypeptide Having A Xylose Import Activity | 2017-01-19 |
20170015715 | COBALAMIN ACQUISITION PROTEIN AND USE THEREOF | 2017-01-19 |
20170015716 | STABILIZED ANTI-MICROBIAL PEPTIDES | 2017-01-19 |
20170015717 | METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS | 2017-01-19 |
20170015718 | PRO-APOPTOTIC RAS AND RAF PEPTIDES | 2017-01-19 |
20170015719 | CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST | 2017-01-19 |
20170015720 | CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES | 2017-01-19 |
20170015721 | CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF | 2017-01-19 |
20170015722 | SUPERAGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 | 2017-01-19 |
20170015723 | RECOMBINANT HUMAN INTERFERON-LIKE PROTEINS | 2017-01-19 |
20170015724 | Growth Hormone Receptor Agonists | 2017-01-19 |
20170015725 | PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE | 2017-01-19 |
20170015726 | TARGETED THERAPEUTICS | 2017-01-19 |
20170015727 | METHODS FOR ENGINEERING T-CELL RECEPTORS | 2017-01-19 |
20170015728 | Novel Substitution Mutant Receptors and Their Use in an Ecdysone Receptor-Based Inducible Gene Expression System | 2017-01-19 |
20170015729 | Factor VIII Fusion Protein | 2017-01-19 |
20170015730 | POLYPEPTIDE COMPOSITIONS WITH TYPE VII COLLAGEN FIBRONECTIN TYPE III-LIKE REPEATS AND TREATMENT METHODS FOR WOUND CLOSURE AND HEALING | 2017-01-19 |
20170015731 | COMPOSITIONS AND METHODS FOR PREPARING A SUBJECT FOR ORGAN OR NON-ORGAN IMPLANTATION | 2017-01-19 |
20170015732 | METHOD FOR PURIFYING IMMUNOGLOBULIN | 2017-01-19 |
20170015733 | BINDING MOLECULES AGAINST CHIKUNGUNYA VIRUS AND USES THEREOF | 2017-01-19 |
20170015734 | Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections | 2017-01-19 |
20170015735 | ANTI-GLUCOSAMINIDASE PASSIVE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS | 2017-01-19 |
20170015736 | ANTIBODIES TO SERICIN AND METHODS AND KITS USING SAME | 2017-01-19 |
20170015737 | ANTI-TRANSTHYRETIN ANTIBODIES | 2017-01-19 |
20170015738 | Antibodies Specific for Hyperphosphorylated Tau and Methods of Use Thereof | 2017-01-19 |
20170015739 | Agents, Uses and Methods for the Treatment of Synucleinopathy | 2017-01-19 |
20170015740 | METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS | 2017-01-19 |
20170015741 | TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT | 2017-01-19 |
20170015742 | BINDING PROTEINS AGAINST VEGF, PDGF, AND/OR THEIR RECEPTORS | 2017-01-19 |
20170015743 | ANTI-ERYTHROPOIETIN ANTIBODIES | 2017-01-19 |
20170015744 | ANTICOAGULANT | 2017-01-19 |
20170015745 | PRODUCTION OF CYTOTOXIC ANTIBODY-TOXIN FUSION IN EUKARYOTIC ALGAE | 2017-01-19 |
20170015746 | DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS | 2017-01-19 |
20170015747 | CD86 ANTAGONIST MULTI-TARGET BINDING PROTEINS | 2017-01-19 |
20170015748 | INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR -SPECIFIC ANTIBODIES AND USES THEREOF | 2017-01-19 |
20170015749 | INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR -SPECIFIC ANTIBODIES AND USES THEREOF | 2017-01-19 |
20170015750 | HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETTA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF | 2017-01-19 |
20170015751 | ACTRIIA BINDING AGENTS AND USES THEREOF | 2017-01-19 |
20170015752 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF | 2017-01-19 |
20170015753 | MULTIVALENT AND MULTISPECIFIC DR5-BINDING FUSION PROTEINS | 2017-01-19 |
20170015754 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40 | 2017-01-19 |
20170015755 | COMBINATION THERAPY COMPRISING ANTI-ANGIOGENESIS AGENTS AND OX40 BINDING AGONISTS | 2017-01-19 |
20170015756 | NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A | 2017-01-19 |
20170015757 | ANTI-FIBULIN-3 ANTIBODIES AND USES THEREOF | 2017-01-19 |
20170015758 | Compositions And Methods For Modulating And Redirecting Immune Responses | 2017-01-19 |
20170015759 | Conjugates of Oligomer of Hyaluronic Acid or of a Salt Thereof, Method of Preparation Thereof and Use Thereof | 2017-01-19 |
20170015760 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | 2017-01-19 |
20170015761 | MODIFIED CONJUGATED DIENE-BASED POLYMER, PREPARATION METHOD THEREFOR, AND RUBBER COMPOSITION CONTAINING SAME | 2017-01-19 |
20170015762 | CONTROLLED RADICAL POLYMERIZATION | 2017-01-19 |
20170015763 | NOVEL ANIONIC POLYMERIZATION INITIATOR AND METHOD FOR PREPARING CONJUGATED DIENE-BASED POLYMER USING SAME | 2017-01-19 |
20170015764 | Methods of Preparing a Catalyst | 2017-01-19 |
20170015765 | CYANINE COLORING COMPOSITION | 2017-01-19 |
20170015766 | POLYBUTADIENE | 2017-01-19 |
20170015767 | Substituted Metallocene Catalysts | 2017-01-19 |
20170015768 | PROCESS CONTROL FOR LONG CHAIN BRANCHING CONTROL IN POLYETHYLENE PRODUCTION | 2017-01-19 |
20170015769 | Boron-Bridged Bis-Indenyl Metallocene Catalyst Systems and Polymers Produced Therefrom | 2017-01-19 |
20170015770 | CATALYST FOR OLEFIN POLYMERIZATION AND CO-POLYMNERIZATION AND A METHOD FOR OLEFIN POLYMERIZATION AND CO-POLYMERIZATION WITH USING THE SAME | 2017-01-19 |
20170015771 | VINYLIDENE FLUORIDE COPOLYMER AND PREPARATION METHOD THEREFOR | 2017-01-19 |
20170015772 | VINYLIDENE FLUORIDE COPOLYMER, METHOD FOR PRODUCING THE SAME, GEL ELECTROLYTE, AND NON-AQUEOUS BATTERY | 2017-01-19 |
20170015773 | NITRILE GROUP-CONTAINING COPOLYMER RUBBER, CROSS-LINKABLE RUBBER COMPOSITION, AND CROSS-LINKED RUBBER | 2017-01-19 |